Serotonin-producing neurons regulate malignancy in ependymoma brain tumors

AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution

New research on the possibility to kill TNBCs by hijacking signals that normally drive mammary gland involution was released in Nature.

October 11, 2024

Vol.50 No.38

In Brief

Cheng-Chia Wu receives St. Baldrick’s grant to support focused ultrasound research for DIPG and DMG

Cheng-Chia “Fred” Wu, assistant professor at Fralin Biomedical Research Institute at Virginia Tech Carilion, received a $115,000 extended scholar grant from St. Baldrick’s to support focused ultrasound research for the treatment of diffuse midline glioma and diffuse intrinsic pontine glioma.

September 13, 2024

Vol.50 No.34

In Brief

Washington University in St. Louis receives $2M from CureSearch for pediatric brain cancer phase I study

CureSearch for Children’s Cancer will award $2 million in funding to support a phase I clinical trial in 24 children and young adults with recurrent brain tumors.

September 06, 2024

Vol.50 No.33

In Brief

Cheng-Chia Wu joins Fralin Biomedical Research Institute at Virginia Tech Carilion

Cheng-Chia “Fred” Wu, a physician-scientist who treats brain tumors in children, has joined Virginia Tech to bring his expertise in focused ultrasound cancer research to the Fralin Biomedical Research Institute at Virginia Tech Carilion.

August 09, 2024

Vol.50 No.32

In Brief

NeOnc Technologies receives California Investment Forum’s Breakthrough Medical Technology Achievement Award

NeOnc Technologies Holdings Inc., a clinical-stage biopharmaceutical company, has received the Breakthrough Medical Technology Achievement Award from the California Investment Forum for its innovations in medical technology related to the treatment of brain and central nervous system diseases.

August 02, 2024

Vol.50 No.31

Clinical Roundup

AI system identifies genes that can convert brain cancer cells into functioning immune cells in mice

In an innovative new study of glioblastoma, scientists used artificial intelligence to reprogram cancer cells, converting them into dendritic cells, which can identify cancer cells and direct other immune cells to kill them.

August 02, 2024

Vol.50 No.31

Serotonin-producing neurons regulate malignancy in ependymoma brain tumors

YOU MAY BE INTERESTED IN

AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution

Cheng-Chia Wu receives St. Baldrick’s grant to support focused ultrasound research for DIPG and DMG

Washington University in St. Louis receives $2M from CureSearch for pediatric brain cancer phase I study

Cheng-Chia Wu joins Fralin Biomedical Research Institute at Virginia Tech Carilion

NeOnc Technologies receives California Investment Forum’s Breakthrough Medical Technology Achievement Award

AI system identifies genes that can convert brain cancer cells into functioning immune cells in mice

Renew today!

Subscriber content

Login